Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 141121 - 141140 out of 493856 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (L01EA02) dasatinib (adm: O) | DASATINIB MSN | 50MG, 50MG TBL FLM 60 , TBC | Retail price with vat |
$0-0 |
$0-0 |
n/a | MSNLABSEUROPELimited,Paola |
| Czech Republic | (L01EA02) dasatinib (adm: O) | DASATINIB VIVANTA GENERICS | 50MG, 50MG TBL FLM 60 , TBC | Retail price with vat |
$0-0 |
$0-0 |
n/a | MSNLABSEUROPELimited,Paola |
| Czech Republic | (L01EA02) dasatinib (adm: O) | DASATINIB MSN | 70MG, 70MG TBL FLM 60 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | MSNLABSEUROPELimited,Paola |
| Czech Republic | (L01EA02) dasatinib (adm: O) | DASATINIB VIVANTA GENERICS | 70MG, 70MG TBL FLM 60 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | MSNLABSEUROPELimited,Paola |
| Czech Republic | (L01EA04) bosutinib (adm: O) | BOSULIF | 100MG, 100MG TBL FLM 28 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01EA04) bosutinib (adm: O) | BOSULIF | 500MG, 500MG TBL FLM 28 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01ED05) lorlatinib (adm: O) | LORVIQUA | 100MG, 100MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01ED05) lorlatinib (adm: O) | LORVIQUA | 25MG, 25MG TBL FLM 90 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01EN02) pemigatinib (adm: O) | PEMAZYRE | 13,5MG, 13,5MG TBL NOB 14 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteBiosciencesDistributionB.V.,Amsterdam |
| Czech Republic | (L01EN02) pemigatinib (adm: O) | PEMAZYRE | 4,5MG, 4,5MG TBL NOB 14 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteBiosciencesDistributionB.V.,Amsterdam |
| Czech Republic | (L01EN02) pemigatinib (adm: O) | PEMAZYRE | 9MG, 9MG TBL NOB 14 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteBiosciencesDistributionB.V.,Amsterdam |
| Czech Republic | (L01EX04) vandetanib (adm: O) | CAPRELSA | 100MG, 100MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | SanofiB.V.,Amsterdam |
| Czech Republic | (L01EX04) vandetanib (adm: O) | CAPRELSA | 300MG, 300MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | SanofiB.V.,Amsterdam |
| Czech Republic | (L01EX07) cabozantinib (adm: O) | COMETRIQ | 20MG+80MG, 20MG+80MG CPS DUR 112(84+28) , BLI | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | IpsenPharma,Boulogne-Billancourt |
| Czech Republic | (L01EX12) larotrectinib (adm: O) | VITRAKVI | 20MG/ML, 20MG/ML POR SOL 2X50ML , LAG | Retail price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAG,Leverkusen |
| Czech Republic | (L01FF01) nivolumab | OPDIVO | 10MG/ML, 10MG/ML INF CNC SOL 1X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Dublin |
| Czech Republic | (L01FF01) nivolumab | OPDIVO | 10MG/ML, 10MG/ML INF CNC SOL 1X4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Dublin |
| Czech Republic | (L01FF01) nivolumab | OPDIVO | 10MG/ML, 10MG/ML INF CNC SOL 1X24ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Dublin |
| Czech Republic | (L01FF01) nivolumab | OPDIVO | 10MG/ML, 10MG/ML INF CNC SOL 1X12ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Dublin |
| Czech Republic | (L01XA03) oxaliplatin | OXALIPLATIN KALCEKS | 5MG/ML, 5MG/ML INF CNC SOL 1X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | ASKalceks,Riga |
Pages
